Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2 - Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients

By Le Brun P.P.H.   de Boer A.H.   Mannes G.P.M.   de Frature D.M.I.   Brimicombe R.W.   Touw D.J.   Vinks A.A.   Frijlink H.W.   Heijerman H.G.M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 1, 2002-07 ,pp. : 25-32

Elsevier

Access to resources Recommend Favorite

Inhaled mannitol in cystic fibrosis

By Wills Peter J  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 1121-1126

Informa Healthcare

Access to resources Recommend Favorite

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

By de Boer A.H.   Le Brun P.P.H.   van der Woude H.G.   Hagedoorn P.   Heijerman H.G.M.   Frijlink H.W.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 1, 2002-07 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

Aztreonam Lysine for Inhalation Solution: In Cystic Fibrosis

By Plosker Greg L.  

Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. : 1843-1855

Adis International

Access to resources Recommend Favorite

Formulation and Evaluation of Insulin Dry Powder for Inhalation

By Mahesh Kumar T.   Misra Ambikanandan  

Drug Development and Industrial Pharmacy, Vol. 32, Iss. 6, 2006-06 ,pp. : 677-686

Informa Healthcare

Access to resources Recommend Favorite